Top Suppliers:I want be here
Related CAS#:
1132940-31-8 1132936-00-5
1235560-28-7 147388-83-8
587870-77-7 189498-57-5
203564-54-9 1145655-58-8
1003021-91-7 1132935-63-7
78210-37-4 2089624-43-9
2228426-64-8 109125-53-3
1204298-46-3 18318-70-2
1083335-90-3 315684-51-6
173069-69-7 1824863-68-4

1132940-31-8

1132940-31-8 structure
1132940-31-8 structure
  • Name: ABT-072 potassium trihydrate
  • Chemical Name: ABT-072 potassium trihydrate
  • CAS Number: 1132940-31-8
  • Molecular Formula: C24H32KN3O8S
  • Molecular Weight: 561.69
  • Catalog: Signaling Pathways Anti-infection HCV
  • Create Date: 2021-12-19 20:23:08
  • Modify Date: 2025-08-27 17:56:04
  • ABT-072 (potassium trihydrate) is an orally active and potent non-nucleoside HCV NS5B polymerase inhibitor (HCV GT1a EC50=1 nM; HCV GT1b EC50=0.3 nM)[1][2][3].
Name ABT-072 potassium trihydrate
Description ABT-072 (potassium trihydrate) is an orally active and potent non-nucleoside HCV NS5B polymerase inhibitor (HCV GT1a EC50=1 nM; HCV GT1b EC50=0.3 nM)[1][2][3].
Related Catalog
Target

NS5B Polymerase[1]

In Vitro ABT-072 (potassium trihydrate) is a non-nucleoside NS5B polymerase inhibitor with nanomolar potency in vitro against genotype 1a and 1b hepatitis C virus polymerases[1].
In Vivo ABT-072 (5 and/or 30 mg/kg; i.v. or p.o.) (potassium trihydrate) shows good PK properties[3]. ABT-072 (2.5 and/or 30 mg/kg; i.v. or p.o.) (potassium trihydrate) shows low plasma clearance and high oral bioavailability[3]. Animal Model: Rats[3] Dosage: 5 and/or 30 mg/kg (Pharmacokinetic Analysis) Administration: I.v. or p.o. Result: Showed good PK properties. Animal Model: Dog[3] Dosage: 2.5 or 30 mg/kg (Pharmacokinetic Analysis) Administration: I.v. or p.o. Result: Showed low plasma clearance and high oral bioavailability.
References

[1]. Lawitz E, et al. A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1. J Hepatol. 2013;59(1):18-23.

[2]. Shi Y, et al. Assessing Supersaturation and Its Impact on In Vivo Bioavailability of a Low-Solubility Compound ABT-072 With a Dual pH, Two-Phase Dissolution Method. J Pharm Sci. 2016;105(9):2886-2895.

[3]. Randolph JT, et al. Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral Bioavailability. J Med Chem. 2018;61(3):1153-1163.
Molecular Formula C24H32KN3O8S
Molecular Weight 561.69
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Chemsrc provides CAS#:1132940-31-8 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 1132940-31-8 | Chemsrc address: https://m.chemsrc.com/en/baike/1687067.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved